Kaposi sarcoma (KS) is considered one of the most common neoplasms in HIV-positive patients. Herein we report a case of an HIV-positive man diagnosed 6 years prior who had never received highly active anti-retroviral therapy (HAART) who presented with anasarca and cutaneous KS. The patient was found to have significant hypoalbuminemia in the setting of normal renal and liver function. An esophagogastroduodenoscopy (EGD) and fecal alpha-1 antitrypsin assay revealed that the patient had a protein-losing enteropathy secondary to gastrointestinal involvement of KS. Additionally, a vertebral body biopsy of a lytic bone lesion found on computed tomography (CT) scan revealed osseous involvement of KS. Our patient provides an interesting case of diffuse KS, a fairly uncommon presentation as many patients now receive HAART and osseous involvement is rare.
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Kaposi sarcoma (KS) is considered one of the most common neoplasms in HIV-positive patients. Since the advent of highly active antiretroviral therapy (HAART) in the mid-1990s, there has been a significant decrease in both the risk of developing KS 1 as well as the incidence of this disease. 2, 3 Numerous reports of AIDS-related KS illustrate its diffuse nature as it can involve the skin, lungs, gastrointestinal tract, liver, and spleen. [4] [5] [6] [7] [8] [9] In rare instance, KS can involve the bones. 4 A 24-year-old Hispanic male with a six year history of HIV who had never received HAART presented with increasing lower extremity swelling over the last three months. The swelling had spread to his thighs and inguinal region involving the scrotum, and it had progressed to the point that he was unable to urinate. He reported a history of intermittent fevers, difficulty swallowing, hemoptysis, hematemesis, loose watery stools, and bright red blood per rectum. At the time of admission, his vitals were stable and he appeared cachectic. On physical exam, there was 3+ pitting edema in the lower INTRODUCTION extremities and flanks, scrotal edema, and moderate upper extremity edema. He had multiple red-purple plaques and nodules on his arms, chest, face, and inguinal region ( Figure 1A ), diffuse lymphadenopathy, and oral candidiasis. Additionally, the patient reported that when he was diagnosed with HIV he did not feel sick so he did not follow up with a physician for treatment.
His labs revealed a serum albumin of <1.0 g/dl and total protein of 4.0 g/dl while his BUN, crea- (Table 1) . Additionally, the patient was severely anemic but would not accept blood transfusion as he was a Jehovah's Witness. Skin biopsies of red-purple lesions on the forearm and inguinal region were positive for KS. In order to ascertain the extent of this patient's KS for cancer staging, a CT scan of the chest, abdomen, and pelvis was performed. It showed multiple lowdensity lesions in the liver and spleen, small bowel wall edema, and multifocal osseous lytic lesions in the spine and ribs which were concerning for lymphoma ( Figure 2 ). Due to this patient's hypoalbuminemia and anemia, liver and spleen biopsies were not performed, but they were suspected to be KS. An inguinal lymph node core needle biopsy was found to have spindle tumor cells positive for HHV-8, SMA, and CD34 and negative for S100 and desmin, consistent with KS ( Figure 3 ). Based on the patient's history of hemoptysis and hematemesis, he underwent an EGD and was empirically started on fluconazole for treatment of oral candidiasis. A stomach corpus biopsy (Figure 4 ) was positive for KS and there was no evidence of esophageal candidiasis. As fecal alpha-1 antitrypsin levels have been shown to be an adequate measure for protein loss through the gastrointestinal tract and are significantly elevated in cases of KS, 10-14 the elevated level obtained (252 mg/dl) was consistent with a protein-losing enteropathy. The patient also had sputum cultures positive for Klebsiella pneumonia and blood cultures positive for Campylobacter jejunii. These findings in addition to the diffuse involvement of KS were suspected as likely causes for his presenting complaints of hematemesis, hemoptysis, and bright red blood per rectum.
In order to investigate the cause of the lytic bone lesions found on CT (Figure 2 ), the patient underwent bone marrow and vertebral body biopsies. Both biopsies were negative for lymphoma, while the vertebral biopsy was positive for KS. Based on the above findings demonstrating diffuse KS, the patient was started on a regimen of pegylated liposomal doxorubicin at 20 mg/m 2 in addition to HAART consisting of darunavir, ritonavir, emtricitabine, and tenofovir.
After the patient was discharged, he was readmitted a total of five times over a period of four months for severe Clostridium difficile colitis and spontaneous bacterial peritonitis. He also experienced significant nausea, vomiting, and progressive dysphagia that prevented him from taking all of his medications as prescribed. An EGD revealed an esophageal web, which likely developed as a result of his vomiting and irondeficiency anemia. The triad of dysphagia, iron deficiency anemia, and esophageal webs is also known as Plummer-Vinson syndrome, a rare condition of unknown etiology that typically affects middle-aged Caucasian women and is treated with iron supplementation and mechanical dilation. 15 In order to improve medication adherence, all HAART medications were transitioned to liquid forms. Despite these changes, he was only able to take his medications sporadically as he continued to have odynophagia and was not a candidate for an esophageal dilation procedure to treat the esophageal web. After starting HAART, the patient achieved viral suppression with an undetectable viral load, but when he was no longer able to take his medications his viral load increased to 2043 copies/ml with a CD4 count of 57 cells/mm 3 . Abacavir was added to his initial regimen given the rise in his viral load and history of medication nonadherence while a genotype study was pending.
Unfortunately, his health continued to deteriorate and within the span of four months he only received a total of four treatments of doxorubicin that were administered off schedule. It was noted that the cutaneous KS became much more extensive ( Figure 1B ) during this time. In order to determine if the progression of this patient's disease was due to a more virulent form of KS, 
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a genomic analysis of the KS lesion from the stomach corpus biopsy was performed. This study found 0 mutations in over 400 cancer-related gene sequences surveyed, which suggests that this patient's disease worsened as a result of his inability to tolerate his medications. After his last hospitalization, he and his family decided to discontinue HAART and chemotherapy, and he went home on hospice care.
KS was once a commonly encountered AIDSdefining illness prior to the widespread availability of HAART. [1] [2] [3] In fact, between 2001-2005 the number of cases of KS dropped by 84% compared to 1991-1995 when HAART was in its early stages. 16 Important risk factors for developing KS include a delay in starting HAART and a low CD4 count, the latter being the most significant. 17 In addition to the cutaneous, gastrointestinal, and osseous KS described in this case, KS can also involve the lungs, liver, and spleen. [4] [5] [6] [7] [8] [9] The patient presented with anasarca and severe hypoalbuminemia with a serum albumin level of <1 g/dl. Hypoalbuminemia can be caused by decreased hepatic synthesis or abnormal excretion in the urine; however, patient's liver function tests, BUN, creatinine, and urine studies were normal (Table 1) . Therefore, alternate causes including a protein-losing enteropathy were considered.
Gastrointestinal involvement of KS may cause hemorrhage, diarrhea, occlusion, perforation, and a protein-losing enteropathy. 13 One way to diagnose a protein-losing enteropathy is to measure levels of fecal alpha-one antitrypsin. [10] [11] [12] [13] [14] Alpha-one antitrypsin is a protease inhibitor with a molecular weight similar to albumin. When it leaks into the intestine, it is neither degraded nor reabsorbed. 10, 12 Therefore, it is an intact protein when excreted into the stool, and elevated levels of fecal alpha-one antitrypsin are a reliable indicator of protein-losing enteropathies. [10] [11] [12] [13] [14] Our patient had significantly elevated fecal alphaone antitrypsin levels at 252 mg/dl. The stomach corpus biopsies taken during the EGD (Figure 4) were positive for KS, which confirmed that the protein-losing enteropathy was due to KS involvement. Albumin loss in the gastrointestinal tract is due to a disruption of the vascular endothelium by KS. 13 Additional factors that likely contributed to this patient's hypoalbuminemia include malnutrition and cancer cachexia. 14 Therefore, the patient's initial symptoms of anasarca and bloody diarrhea were attributed to gastrointestinal KS.
KS involvement of the bone is uncommon. A literature review by Caponetti et al. 4 found 66 case reports of musculoskeletal KS, and of these 27 were AIDS-related osseous KS. Osseous involvement is usually due to spread from an adjacent area and very rarely is it the primary site of KS. 4, 7 It is best visualized with magnetic resonance imaging (MRI) as a CT scan can miss cortical lesions or adjacent soft tissue tumor. Typically these lesions are osteolytic, and similar appearing lesions in the differential diagnosis include bacillary angiomatosis, mycobacterial spindle cell pseudotumor, pyogenic granuloma, arteriovenous malformation, hemangioendothelioma, metastatic solid tumors, and angiosarcoma. 4, 5 The pattern of involvement in AIDS patients typically includes the axial skeleton with the skull, vertebra, pelvis, ribs, and sternum being most commonly involved in order of reported incidence. 4 Although many patients report bone pain, patients reported minimal to no symptoms in case reports of extensive osteolytic lesions. 4 Di Bella et al. 5 reviewed 11 cases of vertebral AIDS-related KS, and found that these patients were men between the ages of 25-37 years with CD4 counts <200 cells/mm 3 , and the majority also had cutaneous involvement. Caponetti et al. 4 found that in the cases of AIDS-DISCUSSION related KS, CD4 counts ranged from 0-128 cells/ mm 3 . A literature review of 11 cases of vertebral KS by Isenbarger et al. 6 found that 36% of patients also had involvement of the gastrointestinal tract.
The treatment for KS in HIV-positive individuals can vary. For those already diagnosed with KS, initiating HAART is associated with an overall prolonged survival rate. 18 The staging of the KS is also important as it can help guide therapeutic management of the patient. The AIDS Clinical Trials Group classification 19 stages KS based on extension of the tumor (T), CD4 count reflecting the degree of immunosuppression (I), and systemic signs (S). Given this patient's widespread tumor burden (T1), CD4 count of less than 150 (I1), tumor-associated edema, and involvement of the viscera and oral candidiasis (S1), his KS was classified as T1-I1-S1. A study by El Ameri et al. 20 found that in T1 stage KS, a CD4 count <200 cells/µl and plasma positive for HHV8 DNA were associated with a poor prognosis, defined as death or initiation of chemotherapy to treat KS. In addition to HAART, patients with extensive KS may benefit from chemotherapy. 9, 21, 22 Currently, pegylated liposomal doxorubicin (PLD) and daunorubicin citrate liposome (DNX) are the first-line systemic therapies for advanced AIDS-related KS. 9, 22 In a study by Martin-Carbonero et al., 21 PLD added to HAART was associated with a 76% response rate compared to 20% with HAART alone. As our patient was untreated for many years, he eventually developed disseminated KS involving bone, which is not often seen. Furthermore, the inability to tolerate HAART was seen as a major factor that led to the progression of his disease. Overall, this patient's case illustrates the array of complications that can develop without appropriate initiation of HAART as well as the difficulties in managing medication side effects and diagnostic challenges encountered in patients with advanced AIDS.
• AIDS patients with Kaposi sarcoma may present with disseminated disease if not on HAART.
• In patients with Kaposi sarcoma and hypoalbuminemia, consider gastrointestinal involvement and a protein-losing enteropathy in the differential. Protein loss in the stool can be detected using a fecal alpha-1 antitrypsin assay as this protein is neither degraded nor secreted in the gastrointestinal tract.
• Although rare, Kaposi sarcoma can be a cause for lytic bone lesions in AIDS patients, and it is best visualized with MRI. The differential diagnosis also includes bacillary angiomatosis, mycobacterial spindle cell pseudotumor, pyogenic granuloma, arteriovenous malformation, hemangioendothelioma, metastatic solid tumors, and angiosarcoma.
• Management of medication side effects and identifying means to improve adherence are equally as important as prescribing the appropriate treatment.
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